Announcement on Obtaining the Drug Registration Certificate for Azacitidine for Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining the Drug Registration Certificate for Azacitidine for Injection
Filed with SSE · · 2 pages · Chinese
Release
Guizhou Yibai Pharmaceutical Co. Ltd. on 6ix
Earlier from Guizhou Yibai Pharmaceutical
- Earnings Preannouncement for 2025
- Indicative Announcement on Expected Loss in Performance for 2025
- Announcement on Changing Annual Audit Institution’s Signatory Certified Public Accountant
- Announcement on Pledge and Pledge Release of Some Shares Held by Controlling Shareholder
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Later from Guizhou Yibai Pharmaceutical
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Provision for Impairment of Related Assets in 2025
- Announcement on Attending 2026 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2025 Annual Performance Briefing
- Announcement on Changing the Use of Shares Repurchased and Cancellation and Notice to Creditors
- Announcement on Resolutions of the 17th Meeting of the 8th Board of Directors
Follow Guizhou Yibai Pharmaceutical into a list and get an email when it puts out news.
Follow Guizhou Yibai Pharmaceutical